Literature DB >> 29278644

Endothelial cells of extremely premature infants display impaired immune response after proinflammatory stimulation.

Lukas Wisgrill1, Martina Muck1, Isabelle Wessely1, Angelika Berger1, Andreas Spittler2, Elisabeth Förster-Waldl1, Kambis Sadeghi1.   

Abstract

BackgroundEndothelial cells (ECs) exert immunological functions such as production of proinflammatory cytokines/chemokines as well as facilitation of extravasation of immune cells into infected tissue. Limited data are available on the functionality of ECs from extremely preterm neonates during infection. Accordingly, the aim of our study was to investigate the immune response of premature ECs after proinflammatory stimulation.MethodsCell adhesion receptors' expression and function, nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NFκB) signaling, and chemokine production were analyzed in umbilical cord ECs from extremely preterm and term neonates after proinflammatory stimulation.ResultsP-selectin and E-selectin surface expression as well as NFκB signaling were lower after lipopolysaccharide (LPS) stimulation in premature ECs. Preterm ECs exhibited lower, but significant, cell-adhesive functions after LPS stimulation compared with term ECs. CCL2/CXCL8 chemokine secretion was significantly upregulated after proinflammatory stimulation in both groups. CXCL10 production was significantly increased in term but not in preterm ECs upon stimulation with tumor necrosis factor compared with unstimulated ECs.ConclusionExtremely premature ECs showed partly reduced expression levels and function of cell adhesion molecules. Both NFκB signaling and chemokine/cytokine production were reduced in premature ECs. The diminished endothelial proinflammatory immune response might result in impaired infection control of preterm newborns rendering them prone to severe infection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29278644     DOI: 10.1038/pr.2017.202

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  26 in total

1.  Cxc chemokine receptor expression on human endothelial cells.

Authors:  C Murdoch; P N Monk; A Finn
Journal:  Cytokine       Date:  1999-09       Impact factor: 3.861

2.  Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues.

Authors:  Barbara J Stoll; Nellie I Hansen; Pablo J Sánchez; Roger G Faix; Brenda B Poindexter; Krisa P Van Meurs; Matthew J Bizzarro; Ronald N Goldberg; Ivan D Frantz; Ellen C Hale; Seetha Shankaran; Kathleen Kennedy; Waldemar A Carlo; Kristi L Watterberg; Edward F Bell; Michele C Walsh; Kurt Schibler; Abbot R Laptook; Andi L Shane; Stephanie J Schrag; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2011-04-25       Impact factor: 7.124

Review 3.  Role of Toll-like receptors, NOD-like receptors and RIG-I-like receptors in endothelial cells and systemic infections.

Authors:  Bastian Opitz; Julia Eitel; Karolin Meixenberger; Norbert Suttorp
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

4.  Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13.

Authors:  A Marfaing-Koka; O Devergne; G Gorgone; A Portier; T J Schall; P Galanaud; D Emilie
Journal:  J Immunol       Date:  1995-02-15       Impact factor: 5.422

Review 5.  Selectins: initiators of leucocyte adhesion and signalling at the vascular wall.

Authors:  Rodger P McEver
Journal:  Cardiovasc Res       Date:  2015-05-20       Impact factor: 10.787

6.  Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines.

Authors:  S K Gupta; P G Lysko; K Pillarisetti; E Ohlstein; J M Stadel
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

7.  Neutrophil and endothelial adhesive function during human fetal ontogeny.

Authors:  Claudia Nussbaum; Anna Gloning; Monika Pruenster; David Frommhold; Susanne Bierschenk; Orsolya Genzel-Boroviczény; Ulrich H von Andrian; Elizabeth Quackenbush; Markus Sperandio
Journal:  J Leukoc Biol       Date:  2012-12-11       Impact factor: 4.962

8.  Reduced TNF-α response in preterm neonates is associated with impaired nonclassic monocyte function.

Authors:  Lukas Wisgrill; Alina Groschopf; Elisabeth Herndl; Kambis Sadeghi; Andreas Spittler; Angelika Berger; Elisabeth Förster-Waldl
Journal:  J Leukoc Biol       Date:  2016-03-10       Impact factor: 4.962

Review 9.  Physiology and pathophysiology of selectins, integrins, and IgSF cell adhesion molecules focusing on inflammation. A paradigm model on infectious endocarditis.

Authors:  Christos Golias; Anna Batistatou; Georgios Bablekos; Alexandros Charalabopoulos; Dimitrios Peschos; Panagiotis Mitsopoulos; Konstantinos Charalabopoulos
Journal:  Cell Commun Adhes       Date:  2011-09-05

Review 10.  Role of pattern-recognition receptors in cardiovascular health and disease.

Authors:  J A Mitchell; B Ryffel; V F J Quesniaux; N Cartwright; M Paul-Clark
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

View more
  3 in total

Review 1.  Neonatal Sepsis and Hemostasis.

Authors:  Dimitra Gialamprinou; Georgios Mitsiakos; Georgios N Katsaras; Christos-Georgios Kontovazainitis; Paraskevi Karagianni; Emmanuel Roilides; Gili Kenet
Journal:  Diagnostics (Basel)       Date:  2022-01-20

2.  Proinflammatory Endothelial Phenotype in Very Preterm Infants: A Pilot Study.

Authors:  Giacomo S Amelio; Livia Provitera; Genny Raffaeli; Ilaria Amodeo; Silvia Gulden; Valeria Cortesi; Francesca Manzoni; Nicola Pesenti; Matteo Tripodi; Valentina Pravatà; Caterina Lonati; Gaia Cervellini; Fabio Mosca; Giacomo Cavallaro
Journal:  Biomedicines       Date:  2022-05-20

3.  Sex-dependent differences in the secretome of human endothelial cells.

Authors:  Maria Grazia Cattaneo; Cristina Banfi; Maura Brioschi; Donatella Lattuada; Lucia M Vicentini
Journal:  Biol Sex Differ       Date:  2021-01-07       Impact factor: 5.027

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.